Oruka Therapeutics, Inc. (ORKA)
CIK 907654 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Oruka Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 2, 2026 | 144 | 0001950047-26-010585 |
| Nov 2, 2026 | 4 | 0000907654-26-000112 |
| Oct 26, 2026 | 8-K | 0001213900-26-112281 |
| Oct 20, 2026 | 4 | 0000907654-26-000110 |
| Oct 15, 2026 | 4 | 0000907654-26-000108 |
| Oct 15, 2026 | 144 | 0001950047-26-010266 |
| Oct 13, 2026 | 144 | 0001950047-26-010177 |
| Oct 13, 2026 | 4 | 0000907654-26-000106 |
| Oct 2, 2026 | 4 | 0000907654-26-000104 |
| Oct 1, 2026 | 144 | 0001950047-26-009940 |
| Sep 21, 2026 | 4 | 0000907654-26-000102 |
| Sep 21, 2026 | 144 | 0001950047-26-009701 |
| Sep 21, 2026 | 4 | 0000907654-26-000100 |
| Sep 15, 2026 | 4 | 0000907654-26-000096 |
| Sep 15, 2026 | 4 | 0000907654-26-000095 |
| Sep 15, 2026 | 4 | 0000907654-26-000098 |
| Sep 15, 2026 | 4 | 0000907654-26-000097 |
| Sep 15, 2026 | 4 | 0000907654-26-000094 |
| Sep 1, 2026 | 4 | 0000907654-26-000087 |
| Sep 1, 2026 | 144 | 0001950047-26-008954 |
| Sep 1, 2026 | 4 | 0000907654-26-000088 |
| Sep 1, 2026 | 144 | 0001950047-26-008949 |
| Aug 28, 2026 | 424B5 | 0001213900-26-095041 |
| Aug 27, 2026 | EFFECT | 9999999995-26-002787 |
| Aug 25, 2026 | 4 | 0000907654-26-000084 |